Article info
Perspective
Payer decision-making with limited comparative and cost effectiveness data: the case of new pharmacological treatments for gout
- Correspondence to Laura T Pizzi
, Jefferson School of Pharmacy, 130 South 9th Street, Philadelphia, PN 19107, USA; laura.pizzi{at}jefferson.edu
Citation
Payer decision-making with limited comparative and cost effectiveness data: the case of new pharmacological treatments for gout
Publication history
- First published February 18, 2012.
Online issue publication
July 28, 2012
Article Versions
- Previous version (18 February 2012).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions